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Ankle arthrodesis, subtalar joint fusion, and total ankle replacement are known to be associated with severe and prolonged postoperative pain. 1 Pain in the territories of the tibial and peroneal nerves has been shown to be well controlled by the use of a popliteal nerve catheter for continuous 2 or patient-controlled 3 4 local anaesthetic application.
However, pain in the area of the saphenous nerve has been reported. 5 When blocked in the groin, at the level where the femoral nerve is blocked, the saphenous nerve can be blocked with a success rate of 95%. 6 The aim of this prospective, randomized, controlled, and open study was to investigate the analgesic effect of a continuous femoral catheter added to a continuous popliteal catheter after major ankle surgery; we hypothesized that the addition of a continuous femoral catheter would enhance the quality of postoperative analgesia. The primary endpoint was postoperative pain intensity in the first 48 postoperative hours; secondary endpoints were postoperative morphine consumption and pain at rest and during movement 6 months after surgery.
Methods
After approval of the local ethical committee (Kantonale Ethikkommission, Gesundheitsdirektion des Kantons Zü rich) and written informed consent were obtained, 53 adult patients of both sexes (classified as ASA physical status I -III, aged 18-75 yr, body mass index of 20 -40 kg m 22 ) undergoing elective major ankle surgery involving both the lateral and medial parts of the ankle were included. Written informed consent was obtained during the preoperative consultation 1 week before hospital admission. Exclusion criteria were myocardial infarction within the last 6 months, chronic pain, preoperative opioid therapy, known allergy to one of the study drugs, inability to use or understand a patient-controlled analgesia (PCA) device, infection at the nerve block puncture site, known neuropathy, and chronic liver and/or renal disease with laboratory values over twice the upper limit of normal. Secondary exclusion criteria after randomization were inappropriate catheter placement (no sensory and motor block 20 min after block performance), catheter dislocation, or accidental catheter removal before end of study completion. The evening before surgery, patients were instructed on the use of the visual analogue scale (VAS: 0, no pain at all; 100, worst pain imaginable) and the morphine PCA device for rescue analgesia. Group assignment was performed according to a computerized randomization list: Group P received a continuous popliteal catheter for postoperative regional analgesia (without additional continuous femoral catheter); Group PF had an additional continuous femoral catheter (i.e. combined continuous popliteal and femoral catheters). Both groups had an i.v. morphine PCA for rescue analgesia (no basal rate, 2 mg morphine bolus, 10 min lock-out time).
On the day of surgery, all patients were orally premedicated with midazolam (0.1 mg kg 21 with a maximum dose of 7.5 mg) 1 h before regional anaesthesia. After arrival in the preoperative induction room, standard monitoring (electrocardiography, blood oxygen saturation, non-invasive arterial pressure measurement) and peripheral venous access were attained. In all patients, a continuous popliteal catheter was placed with patients in the prone position according to a technique described by our group. 3 4 The proximal end of the metal inner of the 21 G, 100 mm short-bevel needle (Polymedic w , Polyplex, Te me na, Carnières-sur-Seine, France) was connected to a nerve stimulator (Stimuplex HNS  11 w ; B. Braun Melsungen AG, Melsungen, Germany), with the initial setting: 1.4 mA current intensity, 0.1 ms impulse duration with 2 Hz impulse frequency. The final needle position was considered successful when foot inversion 3 4 was obtained with a minimal current output of 0.3-0.4 mA and with an impulse duration of 0.1 s. A 20 G perineural catheter (Polymedic w , Polyplex, Te me na, Bondy, France) was placed with the cannula over needle technique by threading the perineural catheter 3 cm past the tip of the cannula. After subcutaneous tunnelling for 4 -5 cm, the popliteal catheter was fixed with transparent adhesive tape and connected to a 200 nm microfilter. Ropivacaine 0.5% (30 ml) (150 mg) was injected incrementally through the catheter using repeated aspiration tests.
In Group PF after performance of the popliteal catheter as described above, the puncture site for femoral block was located 5 cm below a line joining the anterior superior iliac crest spine and the pubic tubercle and 1-2 cm lateral to the femoral artery. The final needle position was considered to be correct if a 'dancing patella' sign was elicited with minimal current output of 0.3-0.4 mA, at 0.1 ms impulse duration and 2 Hz impulse frequency. Femoral catheter placement was performed in a way similar to that described for the popliteal catheter. Ropivacaine 0.5% (10 ml) (50 mg) was administered incrementally through the catheter using repeated aspiration tests. The popliteal and the femoral nerve blocks were assessed by the attending anaesthetist 30 min after the administration of the local anaesthetics.
Block success for the popliteal block was evaluated using the presence of pins-and-needles-type of paraesthesia at the tip of the first, third, and fifth toes, the degree of sensory block (cold test) was assessed over the distribution area of the tibial, deep, and superficial peroneal nerve every 5 min, for 20 min, and the degree of motor block was assessed over the distribution area of the corresponding nerves (no motor block, partial motor block, and complete motor block) every 5 min, for 20 min. In Group PF, the sensory function (cold test) of the saphenous nerve at the level of the medial malleolus was checked every 5 min for 20 min. Motor weakness of the quadriceps was assessed every 5 min for 20 min. Block success was defined (i) as complete sensory block over all corresponding dermatomes (popliteal block) and over the territory of the saphenous nerve (femoral block) and (ii) complete motor block of the corresponding nerves for the popliteal block and at least a partial motor loss of the quadriceps for the femoral block.
Spinal anaesthesia was performed in all patients because of the use of a thigh tourniquet. Patients were positioned in the lateral decubitus position, with the operated site upward to avoid accidental removal of the perineural catheters during this procedure. A 27 G spinal needle (Whitacre, Becton Dickinson AG, Basel, Switzerland) was introduced at the level L4/5 or L3/4 using a paramedian approach. After free backflow of cerebrospinal fluid, 12.5 -15 mg isobaric bupivacaine 0.5% was slowly injected according to the patient's age, height, and body mass index. Acetaminophen 1 g was administered i.v. and repeated every 6 h until the end of the study. All surgeries were performed by the same surgeon. When necessary for intraoperative sedation, propofol was administered using a target-controlled infusion system (Deltec Croseby 3500, Laubscher, Basel, Switzerland and Diprifusor subsystem, AstraZeneca Ltd, Macclesfield, Cheshire, UK). Sedation was given according to the patient's requests in cases of anxiety, discomfort, or patient's wishes to be slightly sedated. Propofol i.v. infusion was started at 0.2 mg ml 21 at the estimated effect site and slowly titrated up to a maximum of 0.8 mg ml 21 until the patient was comfortable.
The maximum of 0.8 mg ml 21 was set to avoid deep sedation with respiratory depression and loss of airway control. After the end of surgery, patients were transferred to the post-anaesthesia care unit (PACU). When arriving in the PACU, all patients received an i.v. morphine PCA device for rescue analgesia (Pain Management Provider, Abbott AG, Baar, Switzerland) with no basal infusion, a 2 mg bolus, and lock-out time of 10 min. When the upper sensory level of the spinal anaesthesia was below the 10th thoracic dermatome, the criteria according to the modified Aldrete score were fulfilled and the postoperative pain was controlled (VAS ,30), patients were transferred to the ward.
T 0 of the study was defined as 6 h after the end of intrathecal bupivacaine administration. At T 0 , a continuous infusion of ropivacaine 0.3% was started at a rate of 14 ml h 21 until T 24 . At T 24 , the infusion rate was reduced to 0.2% until T 48 . In Group PF, the continuous local anaesthetic infusion through the femoral catheter was initiated at T 0 with ropivacaine 0.2% at a rate of 5 ml h 21 and continued until T 48 . At T 48 , all local anaesthetic infusions were stopped. If pain on the VAS at rest was below 30 within the next 3 h, the catheters were withdrawn. During the study period, additional bolus of i.v. morphine (2 mg) were applied by a member of the acute pain service if VAS was .30 despite appropriate use of the PCA device. According to surgical prescription, patients were allowed to mobilize on the morning of the first postoperative day with crutches without weight-bearing on the operated foot. Therefore, any transient weakness of the quadriceps muscle caused by the femoral nerve catheter did not lead to delayed mobilization. Patients were allowed to partially bear weight after the fifth postoperative day.
A study nurse unaware of the purpose of the study performed data collection. During the night, patients were not specifically awakened for data collection. Data assessment consisted of: (i) Postoperative pain at rest and during mobilization was assessed by means of the VAS. Pain at rest was assessed at arrival in the recovery room, at T 0 , and then every 6 h until T 48 . Pain during mobilization (rolling through a walking step over a flat floor without any weight including dorsal extension and plantar flexion) was evaluated at T 24 and then every 6 h until T 48 . Ankle pain was assessed in detail to distinguish between pain over the medial and over the lateral aspect of the ankle. (ii) Postoperative i.v. morphine consumption was registered separately for the time periods T 0 2T 24 and T 24 -T 48 . Total morphine requirements included morphine application with the PCA device and supplementary morphine bolus. (iii) Nausea and vomiting (graded with a three-point score: 0, no; 1, nausea; 2, vomiting) and pruritus (graded with a three-point score: 0, no; 1, mild, no treatment needed; 2, severe, therapy required) were recorded whenever they occurred. (iv) The level of sedation was assessed using the Ramsay sedation score every 6 h until T 48 . (v) Clinical signs of central nervous system or cardiac local anaesthetic intoxication were noted whenever they occurred. (vi) The puncture points of perineural catheters were observed for infectious complications twice daily. Local inflammation was defined as redness, swelling, or pain on pressure at the catheter insertion site. Local infection was defined as the occurrence of pus around the catheter insertion site.
(vii) To detect the development of new neurological deficits, a clinical examination was performed by one of the investigators (S.B.) with special consideration to weakness, numbness, and paraesthesia in all patients on the day before surgery, 24 h after perineural catheters removal, and 6 months after surgery. (viii) Patients were asked to rate their overall satisfaction with postoperative pain management on a scale ranging from 0 (not satisfied at all) to 10 (very satisfied) 24 h after T 48 . (ix) A clinical follow-up was performed 6 months after operation, during routine surgical consultation in the outpatient clinic. Patients were asked to rate their pain intensity using a VAS at rest and with movement (while walking on the floor with maximal flexion and extension). Additionally, regular pain medication was assessed. A neurological examination was performed separately by both the anaesthetist (S.B.) and the responsible surgeon.
Statistical analysis
A previous pilot study in our department (unpublished data) has shown a variation of pain severity with movement of 30% in this surgical context. A 25% pain reduction in Group PF during the first 48 postoperative hours was considered to be significant. On the basis of these data, a power analysis indicated that a sample size of 25 patients per group was sufficient to have an 80% power with a two-sided 95% significance level. Anticipating a dropout rate of 3%, 53 patients were included in the study. Patient satisfaction scores were compared with the Mann-Whitney test. VAS scores and rescue morphine consumption were analysed using the Mann -Whitney test with Bonferroni's correction for multiple repeated measurements. Adverse effects were compared using the x 2 test. For all determinations, P,0.05 was considered significant. For statistical analysis, the software SPSS for windows, version 11.5 (SPSS Inc., Chicago, IL, USA), was used.
Results
Among 53 randomized patients, 25 in each group completed the study (Table 1 , Fig. 1 ). Mean pain at rest was similar between the two groups at all time points. No patient in either group had pain at arrival in the recovery room. Three patients in Group P reported a VAS of 15-25 when discharged to the ward compared with none in Group PF. Maximal pain at rest occurred in both groups between T 12 and T 30 . In Group P, three patients reported no pain at any time, compared with 12 patients in Group PF (P¼0.04). Postoperative pain during mobilization (Fig. 2) was significantly lower at T 24 , T 30 , T 36 , T 42 , and T 48 in Group PF (P¼0.01). All patients in Group P had pain during mobilization compared with 12 in Group PF, who did not report pain during mobilization at any time (P¼0.03).
In Group PF, morphine consumption was significantly lower from T 0 to T 24 and from T 24 to T 48 . Supplementary morphine Nerve catheters after ankle surgery bolus administration was necessary in 52% of patients in Group PF and in 96% in Group P (P¼0.03) ( Table 2) .
The incidence of postoperative nausea, vomiting, and pruritus was similar in the two groups. No clinical signs of local anaesthetic intoxication were reported. No sign or symptom of perineural catheter infection was observed. At T 48 , redness at the catheter insertion site was observed in seven popliteal catheters in each group and eight femoral catheters in Group PF. No sign or symptom of new neurological complications was observed 24 h after catheter removal in any patient. Patient satisfaction at 24 h after catheter removal was similar in both groups (scores 8.9 and 9.1 in Groups P and PF, respectively).
No patient was lost to follow-up 6 months after surgery, and at this time, all patients were able to walk without a walker. Pain at rest was comparable in both groups, but pain with movement (walking on the floor) was significantly lower in Group PF (Fig. 3) (P¼0.03) . In Group P, two patients reported no pain while walking, compared with nine patients in Group PF (P¼0.03). These 11 patients had no or low (maximal VAS of 15) pain scores during mobilization in the postoperative period. Six months after surgery no patient was using opioids, but five patients in Group P were taking anti-inflammatory agents at regular intervals, compared with one patient in Group PF. No neurological complication was observed in any patient.
Discussion
In this study, we found that the addition of a femoral catheter to a popliteal catheter provided significant better pain control during early mobilization. This positive effect on pain with movement was also observed 6 months after operation.
During our investigation, pain at rest was treated effectively in both groups. Since pain intensity at rest was already low in Group P, a much larger study size would have been necessary to demonstrate a possible significant reduction of pain at rest in Group PF. 7 The maximal pain at rest in our study occurred between T 12 and T 30 . This timeframe is comparable with the results of di Benedetto and colleagues, 5 who performed a study with a popliteal catheter Duration of tourniquet (min) 99 (14) 104 (18) Duration of surgery (min) 114 (37) 117 (26) Type of surgery Ankle arthrodesis (n) 11 9
Ankle prosthesis (n) 14 16 and single-shot femoral nerve block after foot surgery. However, in our study, patients had considerably less pain. This difference might be explained by the vanishing effect of the femoral nerve single-shot block as a short-acting local anaesthetic without additives was given. 8 Pain during mobilization was significantly better controlled in Group PF at any time. It is known that pain with movement (in contrast to pain at rest) cannot be well managed with opioids. 9 The saphenous nerve is the terminal sensitive cutaneous branch of the femoral nerve. It has been shown that all major nerves of the lower leg, including the saphenous nerve, contribute to the innervation of both the capsule of the ankle and the talo-calcaneonavicular joint. 10 During movement, the capsule gets stressed and these movements may explain the higher pain intensities in Group P. The results of this work support this anatomical arrangement and therefore highlight the role of the saphenous nerve in pain during ankle mobilization. The significantly lower postoperative morphine consumption in Group PF and the fact that 12 patients in this group did not need any supplementary morphine confirms the better analgesia provided by two continuous perineural catheters in this surgical context. The results in Group P are in accordance with the findings of Chelly and colleagues 11 who found a significant reduction in morphine comparing continuous popliteal catheters with morphine PCA. The significant lower pain during mobilization at 6 months observed in Group PF can be related to the better pain control in the early postoperative period. There is more and more evidence that the intensity of postoperative pain is linked to the development of the chronification of postoperative pain. The results of this study are in accordance with this concept. Kalso and colleagues 12 were among the first to demonstrate a link between the intensity of postoperative pain and chronic pain after thoracotomy. These results were also supported by Senturk and colleagues 13 and
Pluijms and colleagues. 14 Katz and colleagues 15 found, in a paper looking specifically at risk factors, that early postoperative pain was the only factor that significantly predicted long-term pain. Investigations after iliac crest bone grafting, 16 hernia surgery, 17 hip arthoplasty, 18 and Caesarean sections 19 confirmed that postoperative pain was a risk factor.
The mechanisms responsible for the chronification of postoperative pain are still not well defined. 20 Further studies are needed to elucidate this question. Our observations can be criticized since we did not specify the nerve distribution, the characteristics of pain observed 6 months after operation and its impact on the patient's daily quality of life, or the range of movement in the ankle. These secondary outcome variables should be more closely investigated in further prospective studies.
In the context of two combined continuous nerve blocks, the issue of local anaesthetic toxicity must be considered. It was shown that the simultaneous continuous application of ropivacaine at two different sites can be performed without reaching toxic plasma concentration. 16 21 In this context, we performed a preliminary pilot study (unpublished results), which demonstrated that total and free (¼unbound) ropivacaine plasma concentration were well With regard to the site of saphenous nerve block, it could be argued that a more specific continuous saphenous nerve block in the distal part of the thigh would be more appropriate than a continuous femoral nerve block. This would avoid unnecessary proximal muscle weakness. However, the patients in this study were allowed to be mobilized on the morning of the first postoperative day with crutches without weight-bearing of the operated foot. Therefore, the transient weakness of the quadriceps muscle caused by the femoral nerve catheter did not lead to a delayed mobilization. Conversely, blockade of the saphenous nerve at the level of the groin using a nerve stimulator has the advantage of a higher success rate. Furthermore, the placement of a perineural catheter at this level is easier. 24 We recognize that in our study, a third group with a singleshot saphenous block using ropivacaine 0.5% is lacking. This would have perhaps given information dealing with the controversy surrounding single-shot vs continuous infusion, although it has been shown, in different regional anaesthesia procedures, that a continuous administration of local anaesthetic offers better analgesia compared with single-shot application. 25 Pain was referred to as pain in the ankle, since it was not possible for the patients to reliably distinguish the pain over the medial aspect vs pain over the lateral aspect of the ankle, especially since the whole area was covered with dressings and a cast.
The design of this study may also be criticized since the results can be expected and are not surprising. Ankle surgery involving the medial aspect of the ankle will cause pain in the area innervated by the saphenous nerve. However, how important is the pain specifically related to the saphenous nerve in this context is not known and has never been investigated. This work emphasizes the role of this nerve in the occurrence of pain with movement. For practical reasons, a real double-blinded design was not possible in this investigation-the placement of the femoral catheter was visible for both the patient and the study nurse. We cannot exclude that this point may have influenced the results.
Reviews dealing with anaesthesia for foot surgery do not mention the double-catheter technique. 26 -28 In clinical practice, the effectiveness of this 'double catheter technique' should be balanced against costs, workload, and a possible increase in the risk of complications.
In conclusion, we found that analgesia after major ankle surgery when performed by a combination of continuous popliteal and femoral nerve block significantly reduced early postoperative pain with movement and postoperative morphine consumption. This positive effect was still present 6 months after operation.
